We are live on ! Find out more
DMKJ

David M. Knott Jr Portfolio holdings

AUM $189M Turnover 22.11%
1-Year Est. Return 67.72%
This Fund
S&P 500
This Quarter Est. Return
+20.64%
1 Year Est. Return
+67.72%
3 Year Est. Return
+169.37%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$265M
AUM Growth
+$27M
Cap. Flow
-$19.1M
Cap. Flow %
-7.21%
Top 10 Hldgs %
60.48%
Holding
196
New
11
Increased
11
Reduced
19
Closed
23
Avg Time Held Equity + Options
0.7 years
Top 10 Avg Time Held Equity + Options
0.8 years
Top 20 Avg Time Held Equity + Options
0.7 years
Avg Time Held Equity only
0.7 years
Top 10 Avg Time Held Equity only
0.9 years
Top 20 Avg Time Held Equity only
0.7 years

Top Buys

Rank Stock Value
1
OABI icon
OmniAb
OABI
+$6.67M
2
CSX icon
CSX Corp
CSX
+$2.11M
3
CLMT icon
Calumet Specialty Products
CLMT
+$1.85M
4
SNY icon
Sanofi
SNY
+$1.58M
5
ARDX icon
Ardelyx
ARDX
+$1.44M

Top Sells

Rank Stock Value
1
LGND icon
Ligand Pharmaceuticals
LGND
+$4.51M
2
EIGR
Eiger BioPharmaceuticals, Inc.
EIGR
+$3.08M
3
GLHAW
Glass Houses Acquisition Corp. Warrant
GLHAW
+$2.88M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$2.74M
5
PFE icon
Pfizer
PFE
+$2.35M

Sector Composition

Rank Sector Weight
1 Materials 29.69%
2 Healthcare 28.82%
3 Financials 9.61%
4 Miscellaneous 8.4%
5 Consumer Staples 6.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
VRTX icon
26
Vertex Pharmaceuticals
VRTX
$129B
$2.31M 0.87%
8,000
-9,000
-53% -$2.74M
2021 Q4
4 quarters
AVDL
27
DELISTED
Avadel Pharmaceuticals
AVDL
$2.22M 0.84%
310,251
-80,610
-21% -$565K
2021 Q4
4 quarters
CSX icon
28
CSX Corp
CSX
$90.2B
$2.17M 0.82%
+70,000
New +$2.11M
2022 Q4
0 quarters
GSK icon
29
GSK
GSK
$98.2B
$2.11M 0.8%
60,000
+20,000
+50% +$666K
2022 Q3
1 quarter
TWLVW icon
30
DELISTED
Twelve Seas Investment Company II Warrant
TWLVW
$1.92M 0.72%
166,666
– –
2021 Q4
4 quarters
EXE icon
31
Expand Energy Corp
EXE
$21B
$1.89M 0.71%
20,000
– –
2022 Q2
2 quarters
CVE icon
32
Cenovus Energy
CVE
$59B
$1.84M 0.7%
95,000
– –
2022 Q2
2 quarters
OVV icon
33
Ovintiv
OVV
$18.3B
$1.77M 0.67%
35,000
– –
2022 Q2
2 quarters
AB icon
34
AllianceBernstein
AB
$3.2B
$1.74M 0.66%
50,500
– –
2021 Q4
4 quarters
KAIRW
35
DELISTED
Kairos Acquisition Corp. Warrant
KAIRW
$1.6M 0.61%
139,278
– –
2021 Q4
4 quarters
GMED icon
36
Globus Medical
GMED
$10.6B
$1.55M 0.58%
20,831
+2,000
+11% +$136K
2021 Q4
4 quarters
MOS icon
37
The Mosaic Company
MOS
$6.02B
$1.53M 0.58%
35,000
– –
2022 Q2
2 quarters
BIP icon
38
Brookfield Infrastructure Partners
BIP
$17.1B
$1.4M 0.53%
45,000
– –
2022 Q1
3 quarters
BRIVW
39
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
$1.34M 0.51%
116,666
– –
2021 Q4
4 quarters
FIP icon
40
FTAI Infrastructure
FIP
$303M
$1.25M 0.47%
425,000
– –
2022 Q3
1 quarter
PMGMW icon
41
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$1.15M 0.43%
100,000
– –
2021 Q4
4 quarters
MCRB icon
42
Seres Therapeutics
MCRB
$25.4M
$1.12M 0.42%
10,005
+4,505
+82% +$604K
2022 Q3
1 quarter
CHRS icon
43
Coherus Oncology
CHRS
$162M
$1.02M 0.38%
128,517
-71,483
-36% -$550K
2021 Q4
4 quarters
RHP icon
44
Ryman Hospitality Properties
RHP
$8.65B
$1.01M 0.38%
12,400
-12,000
-49% -$1.03M
2021 Q4
4 quarters
PSTX icon
45
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
$895K 0.34%
168,839
+17,553
+12% +$80.2K
2022 Q3
1 quarter
LOKM.WS
46
DELISTED
Live Oak Mobility Acquisition Corp. Warrants, exercisable for one share of Class A common stock at an exercise price of $11.50 per share
LOKM.WS
$828K 0.31%
72,030
– –
2021 Q4
4 quarters
KMB icon
47
Kimberly-Clark
KMB
$34.6B
$815K 0.31%
6,000
– –
2021 Q4
4 quarters
ABBV icon
48
AbbVie
ABBV
$501B
$814K 0.31%
5,037
-15,000
-75% -$2.3M
2021 Q4
4 quarters
CCOI icon
49
Cogent Communications
CCOI
$428M
$799K 0.3%
14,000
– –
2022 Q1
3 quarters
DD icon
50
DuPont de Nemours
DD
$17.8B
$764K 0.29%
8,872
– –
2021 Q4
4 quarters
1
2
3 4 5

Similar funds

SCA
Sander Capital Advisors Seattle, Washington $189M AUM 13.06% 1-Year Est. Return
FI
FWG Investments Lexington, Kentucky $189M AUM 18.47% 1-Year Est. Return
MFS
Madrid Financial Services Manhattan Beach, California $189M AUM 30.12% 1-Year Est. Return
FRA
FFG Retirement Advisors Centennial, Colorado $189M AUM 16.39% 1-Year Est. Return
CAM
Councilmark Asset Management Knoxville, Tennessee $189M AUM 26.93% 1-Year Est. Return
BAG
Bauman Advisory Group Las Vegas, Nevada $189M AUM
SHC
SALT Holding Corp Wilmington, Delaware $189M AUM 34.63% 1-Year Est. Return
HC
Hara Capital Bellevue, Washington $190M AUM 42.56% 1-Year Est. Return

David M. Knott Jr's Q4 2022 Portfolio in Review

As of Q4 2022, David M. Knott Jr held 196 positions worth $265M, up 11% from $238M the previous quarter. Its ten largest holdings account for 60% of the portfolio.

David M. Knott Jr withdrew a net $19.1M in Q4 2022, closing 23 positions and reducing 19 holdings. Its most notable exit was Eiger BioPharmaceuticals, Inc., an estimated $3.08M position sold in full.

By sector, the portfolio is most concentrated in Materials at 30% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.

Against the trend, David M. Knott Jr opened a new position in OmniAb worth $4.58M.

  • David M. Knott Jr's largest Q4 2022 buy was OmniAb: 1,270,939 shares worth $4.58M.
  • David M. Knott Jr added most to Calumet Specialty Products in Q4 2022, an estimated $1.85M increase.
  • David M. Knott Jr's biggest Q4 2022 reduction was Ligand Pharmaceuticals, cutting an estimated $4.51M.
  • David M. Knott Jr fully exited Eiger BioPharmaceuticals, Inc. in Q4 2022, selling an estimated $3.08M.
  • David M. Knott Jr's ten largest holdings make up 60% of its $265M portfolio in Q4 2022.
  • David M. Knott Jr opened 11 new positions and closed 23 in Q4 2022.
  • David M. Knott Jr's portfolio value rose 11% quarter-over-quarter to $265M.

Based on David M. Knott Jr's 13F filing for Q4 2022, filed 13 Feb 2023.